FairScope Lab
EN 繁中 简中

ZTS

Valuation Healthcare · Drug Manufacturers - Specialty & Generic Data as of 2026-03-31

P/E Ratio · Metrics

P/E Ratio

20.77

PEG Ratio

0.30

Dividend Yield

-

Gross Margin

71.66%

Net Margin

26.57%

Revenue CAGR 3Y

4.19%

ROE

74.36%

ROA

15.86%

Buyback Yield

3.69%

Current Ratio

3.15

Magic Earn Yield

5.75%

Altman Z-Score

4.50

Fair Value River

Score

Valuation 62
Profitability 72
Growth 14
Health 95
Yield 62
← Back to Dashboard